Study the Effect of Dyslipidemia in Iraqi Diabetes Patients with Both Gender

Authors

  • Sahar Abdul Wahab ALShaban Department of Chemistry and Biochemistry, College of Medicine, Mustansiriyah University, Baghdad, Iraq. Author
  • Rasha Kareem Hashim National Diabetes Center/ Mustansiriyah University, Baghdad, Iraq. Author
  • Alyaa Hasan Bohan Department of Basic Sciences-College of Dentistry/ Mustansiriyah University.IRAQ Author
  • Raghda Shams Akram Department of Chemistry and Biochemistry, College of Medicine, Mustansiriyah University, Baghdad, Iraq. Author

Keywords:

Dyslipidemia, cardio vascular disease, T2DM, Gender.

Abstract

The aim of this article to Study the Effect of Dyslipidemia in Iraqi Diabetic Patients with Both Gender. Twenty hindered participant (50) male with dyslipidemia compared with (50) male without dyslipidemia and (50) female with dyslipidemia compared with (50) female without dyslipidemia. There was a highly significant increase of TC,TG and LDL-c in Male with dyslipidemia when compared with Male without dyslipidemia, while a significant decreased of HDL-c in Male with dyslipidemia when compared with Male Control, and a highly significant incased of TC,TG and LDL-c in female with dyslipidemia when compared with female without dyslipidemia .while a significant decreased of HDL-c in female with dyslipidemia when compared with female without dyslipidemia. It can conclude increased TC, TG and LDL-C levels, while decreased level of HDL-C in male and female with dyslipidemia these due to Lipids are a major role in the development of CVD, and controlling these factors has become a top priority for health policymakers of both genders. 

Downloads

Download data is not yet available.

References

T Kassahun Hailel ,. Abebe Timerga. Dyslipidemia and Its

Associated Risk Factors Among Adult Type-2 Diabetic

Patients at Jimma University Medical Center, Jimma,

Southwest Ethiopia. Diabetes, Metabolic Syndrome and

Obesity: Targets and Therapy 2020:13 4589-4597.

-Hirano T. Pathophysiology of diabetic dyslipidemia. J

Atheroscler Thromb. 2018;25(9):771-782.

Ambachew H, Shimelis T, Lemma K. Dyslipidemia among

diabetic patients in Southern Ethiopia. J Diabetes

Endocrinol. 2O15;6 (4):19-24. doi:10.5897/JDE2015.0086

-Daya R, Bayat Z, Raal FJ. Prevalence and pattern of

dyslipidemia in type 2 diabetes mellitus patients at a

tertiary care hospital. J Endocrinol Metab Diabetes.

;22(3):31-35. doi:10.1080/ 16089677.2017.1360064 10.

-Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clin Lipidol. 2011;6 (4):401-411.

doi:10.2217/clp.11.32 11.

-Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism.

;63 (12):1469-1479.

doi:10.1016/j.metabol.2014.08.010 12.

- Hirano T. Pathophysiology of diabetic dyslipidemia. J

Atheroscler Thromb. 2018;25(9):1-12.

doi:10.5551/jat.RV17023 13.

- Schofield JD, Liu Y, Rayaz PR, Malik RA, Soran H.

Diabetes dyslipidemia. Diabetes Ther. 2O16;7(2):2O3-

doi:10.1007/ s13300-016-0167-x 14.

-Goldberg IRAJ. Diabetic dyslipidemia: causes and

consequences. J Clin Endocrinol Metab. 2001;86(3):965-

doi:10.1210/jcem.86.3.7304 15.

- Salim A, Ghouth B, Ba-karman AA, Alaidroos HA, Alajely

MH. Prevalence and patterns of dyslipidemia among

type 2 diabetes mellitus patients in Mukalla City,

Yemen, in 2017. J Community Med Public Health.

;6:6-11.

Kiplagat SV, Lydia K, Jemimah K, Drusilla M. Prevalence

of dyslipidemia, and the associated factors among type

diabetes patients in Turbo Sub-county, Kenya. J

Endocrinol Diabetes. 2017;4(5):1-9. doi:10.15226/2374-

/4/5/00190.

- Ploypun Narindrarangkura , William Bosl , Ram Rangsin

and Panadda Hatthachote. Prevalence of dyslipidemia

associated with complications in diabetic patients: a

nationwide study in Thailand. Narindrarangkura et al.

Lipids in Health and Disease (2019) 18:90.1-9.

-Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W,

Hasani MR, Yusufali AH, et al; INTERHEART

Investigators in Middle East. Association of risk factors

with acute myocardial infarction in Middle Eastern

countries: the INTERHEART Middle East study. Eur J

Prev Cardiol 2014 Apr;21(4):400-410.

-Expert Dyslipidemia Panel of the International

Atherosclerosis Society Panel members. An

International Atherosclerosis Society Position Paper:

global recommendations for the management of

dyslipidemia-full report. J Clin Lipidol 2014 JanFeb;8(1):29-60.

- Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE,

Jones PH, et al. National Lipid Association

recommendations for patient-centered management of

dyslipidemia: part 1 - executive summary. J Clin Lipidol

Sep-Oct;8(5):473-488.

-Khalid Al-Rasadi and Hilal Al-Sabti. Dyslipidemia in the

Arabian Gulf and its Impact on Cardiovascular Risk

Outcome. Oman Medical Journal [2015], Vol. 30, No. 6:

-405. DOI 10.5001/omj.2015.81

-Simon C., Everitt H. & Kendrick T. Oxford Handbook of

General Practice. 2nd Edition. Oxford University Press.

Pp. 712-728 (2005).

-Richmond W. (1992). Analytical reviews in clinical

biochemistry: the quantitative analysis of cholesterol.

Ann. Clin.Biochem. 29(26):577-597.

Fossati .P and Prencipe L.(1982): Serum triglycerides

determined colorimetrically with an enzyme that

produces hydrogen peroxide. Clin.Chern. 28(10):2077-

- Lopes-Virella M., Ston P. and Ellis S. Cholesterol

dtermination in high density lipoprotein separated by

three different methods.Cline.Chern.,23(5):882-884

(1977).

-Friedewald, William T., Robert I., Levy & Donald S.,

Fredrickson Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of

the preparative ultracentrifuge. Clinical Chemistry,

(6):499-502 (1972).

-Helmut JR., and Yvette SL . A simple methods for the

determination of blood urea nitrogen with special

refrnces to automatic collorematric analysis.Clinical

Chemestry . 5(6).1959.

-Larsen ,K.CIin.Chim.Acta.41:204(1972).

-He Z, Liu Z, Liu M, Guo C, Xu R, Li F, et al. Efficacy of

endoscopic screening for esophageal cancer in China

(ESECC): design and preliminary results of a

population-based randomised controlled trial. Gut.

;68(2):198-206. 21.

-Chen W-W, Gao R-L, Liu L-S, Zhu M-L, Wang W, Wang

Y-J, et al. China cardiovascular diseases report 2015: a

summary. J Geriatr Cardiol. 2017;14(1):1-10. 22.

-Weiwei C, Runlin G, Lisheng L, Manlu Z, Wen W, Yongjun

W, et al. Outline of the report on cardiovascular

diseases in China, 2014. Eur Heart J Suppl. 2016;18:F2-

F11. 23.

-Boo S, Yoon YJ, Oh H. Evaluating the prevalence,

awareness, and control of hypertension, diabetes, and

dyslipidemia in Korea using the NHIS-NSC database: a

cross-sectional analysis. Medicine (Baltimore).

O18;97(51): e13713.

- Minmin Wang , Mengfei Liu , Fenglei Li , Chuanhai Guo ,

Zhen Liu , Yaqi Pan , Ying Liu , Fangfang Liu , Hong Cai ,

Yangfeng Wu , Zhonghu He and Yang Ke. Gender

heterogeneity in dyslipidemia prevalence, trends with

age and associated factors in middle age rural Chinese.

Lipids in Health and Disease (2020) 19:135.1-11.

- Waad-Allah S Mula-Abed. Prevalence of dyslipidemia in

the Iraqi adult population.saudi Medical

Journal 28(12):1868-74.

- Hokanson JE. Hypertriglyceridemia and risk of coronary

heart disease. Curr Cardiol Rep. 2002;4(6):488-93

- Ginsberg HN, Zhang YL, Hernandez-Ono A. Metabolic

syndrome: focus on dyslipidemia. Obesity.

;14(Suppl 1):41S-9S.

- Pont F, Duvillard L, Florentin E, Gambert P, Verges B.

Early kinetic abnormalities of apoB-containing

lipoproteins in insulin-resistant women with abdominal

obesity. Arterioscler Thromb Vase Biol.

OO2;22(1O):1726-32.

- Valeska Ormazaball , Soumyalekshmi Nair2 , Omar

Elfeky2 , Claudio Aguayo3 , Carlos Salomon2,3,4* and

Felipe A. Zuniga. Association between insulin resistance

and the development of cardiovascular disease.

Cardiovasc Diabetol (2018) 17:122.

- Yasser Taher Al-Hassan, Eduardo L. Fabella* , Edric

Estrella and Mohammad Aatif. Prevalence and

Determinants of Dyslipidemia: Data from a Saudi

University Clinic. The Open Public Health Journal, 2018,

417-425.

- Stone NJ. Secondary causes of hyperlipidemia.Med Clin

;78: 117e141. PMID: 8283927.

- Chait A, Brunzell JD. Acquired hyperlipidemia

(secondarydyslipoproteinemias).Endocrinol Metab Clin

N Am 1990; 19:259e278. PMID: 2192873.

- Aguilar-Salinas CA, Olaiz G, Valles V, Torres

JMR,Pe rez FJG, Rull JA, et al. High prevalence of low

HDLcholesterol concentrations and mixed

hyperlipidemia in aMexican nationwide survey.J Lipid

Res 2001; 42: 1298e1307.PMID:11483632.

-Brinton EA, Eisenberg S, Breslow JL. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreosingHDL apolipoprotein transport

rates.J Clin Invest 1990; 85:144. PMID: 2104877.

- Mohammed A. AI-DuaisYahya S. Al-Awthan. Prevalence

of dyslipidemia among students of a Yemeni University.

Journal of Taibah University Medical Sciences (2019)

(2), 163-171.

- Hend Soliman* and Amany Ibrahim. Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes. Soliman and Ibrahim Egyptian Pediatric Association Gazette (2021) 69:21

Downloads

Published

2023-04-30

Issue

Section

Articles

How to Cite

Abdul Wahab ALShaban, S., Kareem Hashim, R., Hasan Bohan, A., & Shams Akram, R. (2023). Study the Effect of Dyslipidemia in Iraqi Diabetes Patients with Both Gender. History of Medicine, 9(2). https://historymedjournal.com/HOM/index.php/medicine/article/view/539